Navigation Links
VetCentric Releases Findings of Pet Owner Survey

Data Results in New Compounded Medication Program

GLEN BURNIE, Md., May 7 /PRNewswire/ -- VetCentric, Inc., the nation's largest practice-to-home delivery veterinary pharmacy today announced the results of its recent online survey of more than 1,200 pet owners from across the U.S.

Key findings indicate that pet owners feel very strongly about having convenient services and options that help them improve compliance. It also indicated a very strong preference for ordering medications directly through their veterinary clinics to maintain veterinarian involvement. Specifically:

  • 96% of pet owners stated that it was important to be able to order their pet's medication through their veterinarian to ensure that the vet remained involved with the pet's care (51% stated that this is "very important")
  • 90% of pet owners stated it was important to have the convenience of home delivery for their pet's medications
  • 87% of pet owners stated it was important to have automatic refills of the pet's medications so they didn't have to worry about missing a dose
  • 87% of pet owners stated it was important to have a variety of medication forms and flavorings that make it easier for pets to take their medications

To meet the needs pet owners identified in this research and support its partner practices, VetCentric recently launched a new compounded medications program that provides free home delivery while encouraging treatment regime compliance. The program includes free 2nd day shipping for first fills and free standard shipping for all refills when the prescription is set up to automatically refill. Complete information about the program is available through the recently launched compounding microsite at

"The results of this survey strongly support VetCentric's core belief that veterinarian involvement is crucial to maintaining healthy pets. It's very exciting to see that pet owners feel strongly about both the convenience of home delivery and keeping their veterinarian involved in their pet's care. This data was instrumental in the development of our new compounded medications program," said Ted Root, President and CEO of VetCentric.

More than 1,200 pet owners completed the survey and all of them are clients of clinics that presently have a VetCentric account. Approximately 50% of respondents have placed at least one order through VetCentric.

About VetCentric:

VetCentric, Inc., a privately-held company headquartered in the Baltimore-Washington area, is the only national veterinary-focused pharmacy offering home delivery of FDA and EPA approved pharmaceuticals, compounded medications and diets to pet owners on behalf of veterinary clinics. Its comprehensive suite of services provides clinics with an online store that allows customized product selection and pricing, home delivery and client communications. VetCentric firmly supports the Veterinarian-Client-Patient relationship in all its business practices, allowing veterinarians to stay at the center of their patients' care while improving service, encouraging compliance and decreasing costs.

In the past 10 years, VetCentric has partnered with more than 9,000 veterinary clinics to fill in excess of 2 million orders for nearly 500,000 pet owners. Its pharmacy complies with the licensing and inspection requirements of all states in which it does business. For more information, please visit

SOURCE VetCentric, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VetCentric Partners with Dechra Veterinary Products
2. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
5. Verdict One Releases Directory of Board Certified Attorneys for Consumers
6. Academy releases emergency preparedness tools to enable millions more people to shelter in place
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. MITEM Releases Blue Iris eLaborate 8.6
9. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... for mental health and wellness consultation, has collaborated with Women’s Web – ... their reader’s queries on topics on mental and emotional well-being relationship, life ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... where preparing the perfect dish and pleasing the palates of attendees is of ... bringing a dish to a seasonal get-together, give these recipes a try this ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published November ... more widely heralded as a breakthrough for performing hernia repairs. The article explains that ... surgery is that it can greatly reduce the pain that a patient might otherwise ...
(Date:11/25/2015)... Raton, Florida (PRWEB) , ... November 25, 2015 ... ... diagnostic testing for physicians and athletic programs, launches new Wimbledon Athletics ... importance of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, ... optimizing treatment outcomes for patients suffering from chronic pain, ... for a Temporary Restraining Order (TRO) enjoining Express Scripts ... two companies. --> --> ... all of its legal options. --> ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
Breaking Medicine Technology: